paper 1
Title: Irreversible EGFR Inhibitors in the Treatment of Advanced NSCLC
Journal: Curr Pharm Des
paper 2
Title: Afatinib for the treatment of patients with EGFR-positive non-small
cell lung cancer.
Journal: Drugs Today (Barc). 2013 Sep;49(9):523-35.
my email is f********[email protected]
Thanks! will send boazi.